These compounds may interact with:
Diacylglycerol O-acyltransferase 2
Potentially involved in: carcinoma; fatty liver disease; obesity; lipid metabolism disorder; chemical and drug induced liver injury; astrocytoma, pilocytic; atopic dermatitis; breast carcinoma; ductal carcinoma in situ; fibroadenoma; interstitial cystitis; intraductal papillary-mucinous neoplasm (ipmn); invasive ductal carcinoma; pancreatic ductal adenocarcinoma liver metastasis; pituitary cancer; primitive neuroectodermal tumor; psoriasis; cholestasis
Disease data sourced from Pharos.